CONFERENCE COVERAGE
European Alliance of Associations for Rheumatology
Annual Meeting
2022 COVERAGE
- Influencing Factors of Renal Decline in Lupus Nephritis
- IL-6 and IL-17 Pathway Modulation Following Upadacitinib Treatment for PsA
- COVID-19 Outcomes Similar in Patients With and Without IMIDs
- Upadacitinib Safe and Effective in nr-axSpA
- Perception of Gout as a Lifestyle Disease Reinforces Stigma
- Gender-Specific Recommendations for Improving Diagnostic Accuracy in axSpA
Latest Tweets
Follow
@RheumAdvisor
Conference Coverage from
